Study to Tackle Leading Cause of Death in COVID-19 Patients Lenzilumab is a monoclonal antibody that neutralizes GM-CSF, a cytokine up-regulated in COVID-19 patients that can cause a harmful immune response Clinical evidence suggests that this response contributes to...
Conference call on Monday, March 30, 2020, at 5:00 p.m. ET featuring study investigator Debra L. Richardson, MD CAMBRIDGE, Mass., March 20, 2020 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (MRSN), a clinical-stage biopharmaceutical company focused on...
HANGZHOU, China, March 23, 2020 (GLOBE NEWSWIRE) — AnHeart Therapeutics, Co., Ltd. (“AnHeart”), a clinical stage oncology company focused on underserved patients in global markets, today announced that its new drug candidate taletrectinib has received IND...
Randomizations concluded and trial participation in process of concluding to ensure patient safety during COVID-19 pandemic AXS-05 and placebo arms fully enrolled with estimated completion rate of more than 90% Topline results now expected early 2Q 2020 NEW...
VANCOUVER, British Columbia, March 20, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce today that it has...
Email
Text